在三阴性乳腺癌中,瘤表达的PD-L1通过MAPK/ERK通路调节NT5E表达
Cheng Cheng1,2,3, Chao Shi1,2, Shang Wu1,2
1Breast Center, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
Oncology research
|July 4, 2025
概括
乳腺癌细胞表达的编程细胞死亡配体1 (PD-L1) 通过MAPK/ERK通路调节Ecto-5'-核酶 (NT5E). 抑制PD-L1或NT5E可以减少癌细胞的增殖和转移,从而提供新的免疫治疗点.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 编程细胞死亡1 (PD-1) 抑制剂已成为癌症治疗的先进手段.
- 在癌细胞中,编程细胞死亡配体1 (PD-L1) 的确切作用和机制尚不完全理解.
- 确定乳腺癌免疫治疗的新型治疗点至关重要.
研究的目的:
- 为了研究PD-L1在乳腺癌细胞中的功能.
- 确定PD-L1调节的关键分子点,用于未来的免疫疗法策略.
- 阐明PD-L1通过影响其目标的信号通路.
主要方法:
- 在PD-L1沉默乳腺癌细胞上进行RNA测序 (RNA-seq),以识别差异表达的基因.
- 临床乳腺癌样本上的生物信息学分析和免疫组织化学.
- 在体外验证,包括基因沉默 (siRNA),西式涂抹和增殖/转移分析.
主要成果:
- 在乳腺癌中观察到Ecto-5'-核酶 (NT5E) 和PD-L1表达之间存在显著的正相关性.
- 高NT5E表达与淋巴结转移和整体存活率 (OS) 较差相关.
- 抑制PD-L1通过MAPK/ERK通路减少NT5E表达;降低PD-L1或NT5E抑制癌细胞的增殖和转移.
结论:
- 瘤表达的PD-L1通过MAPK/ERK信号通路调节NT5E.
- 下调PD-L1或NT5E显著抑制乳腺癌细胞的增殖和转移.
- PD-L1和NT5E代表了乳腺癌中联合PD-L1免疫疗法的潜在治疗标和预后标记.
更多相关视频
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
14.8K
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
7.0K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
MAPK Signaling Cascades
6.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
